gonorrhea
The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.
CARB-X Awards $1M Each to Prompt Diagnostics, Fuse Diagnostics for Point-of-Care STI Tests
The funds will support the development of Prompt's test for drug resistant Neisseria gonorrhoeae and Fuse's test for N. gonorrhoeae and Chlamydia trachomatis.
Scout Nabs $1M CARB-X Award for Point-of-Care Molecular STI Test
The company plans to use the funding to demonstrate proof of concept and feasibility for a rapid test to detect chlamydia and gonorrhea.
Binx Health, Cardinal Health Strike US Distribution Deal for Point-of-Care STD Test System
The Binx io molecular diagnostics system runs a test for Chlamydia trachomatis and Neisseria gonorrhoeae that previously received a CLIA waiver.
Visby Medical Secures $1.8M From CARB-X for Gonorrhea and Drug Resistance MDx
The portable, instrument-free PCR test will be used to detect infections resistant to the frontline antibiotic ciprofloxacin and help reduce use of ceftriaxone.